Healthcare -
Biotechnology - NASDAQ - US
$ 40.29
0.977 %
$ 7.35 B
Market Cap
-11.01
P/E
Price Target
Average
42.30%
Revenue Forecast
Estimate
270.59%
EBIT
Estimate
--6.55%
Net Income
Estimate
24.59%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Revolution Medicines, Inc.
Wall Street analysts predict an average 1-year price target for RVMD of $57.3 , with forecasts ranging from
a
low of
$43 to a high of $82 .
RVMD Lowest Price Target
Wall Street Target
43 USD
6.73%
RVMD Average Price Target
Wall Street Target
57.3 USD
42.30%
RVMD Highest Price Target
Wall Street Target
82 USD
103.52%
REVENUE FORECAST
Revenue Forecast Chart RVMD
EBIT FORECAST
EBIT Forecast Chart RVMD
NET INCOME FORECAST
Net Income Chart RVMD